Where does Sangamo Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Sangamo Therapeutics, Inc. ranks #2,668 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Sangamo Therapeutics, Inc. hold?

Sangamo Therapeutics, Inc. holds 146 US utility patents granted between 2017 and 2025, spanning 14 technology areas.

What is Sangamo Therapeutics, Inc.'s Innovation Score?

Sangamo Therapeutics, Inc. has an Innovation Score of 41.8 out of 100 (top 32% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Sangamo Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Sangamo Therapeutics, Inc.'s recent grant velocity is +34% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Sangamo Therapeutics, Inc.'s patents?

Sangamo Therapeutics, Inc.'s patents average 12.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Sangamo Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Sangamo Therapeutics, Inc.

Q: What technology areas does Sangamo Therapeutics, Inc. focus on?

Sangamo Therapeutics, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 143 patents, ranking #58 of 4,144 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

USPTO PatentsView assignee record - 146 granted patents across 14 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Sangamo ranks #2,668 of 49,997 tracked US assignees by granted-patent volume, with 146 patents across 14 technology areas.

#2,668
of 49,997 US assignees by volume: Top 32%
by Innovation Score (41.8/100): 12.3
avg claims per patent: +34%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2668 · US Corporation #2,668 · 146 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 146 grants
TOP-DECILE #2,668/49,997
PHOTO-FINISH Safran Transmission…
CPC-FOCUS C12N · 14 areas
INNOV-PAR 41.8/100
CLAIMS-RICH 12.3 claims/avg
TYPE-USCORP US Corporation
VEL-UP +34% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Safran Transmission Systems (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Sangamo’s 41.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 17.2 pts (41%) Velocity 3.9 pts (9%) Breadth 13.2 pts (32%) Claim depth 7.4 pts (18%)

Qualcomm Incorporated · highest

85
Clover Network · near

42
First Principles · near

42
Innovex Downhole… · near

42
Sangamo Therapeutics · this assignee

42
Simple Living… · near

42
3D Lighting… · lowest

7

What this shows Sangamo's Innovation Score is 41.8/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Sangamo?

Each dot is one of Sangamo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sangamo’s own 12.3 claims/patent is at or below the 12.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Sangamo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Sangamo's grants concentrate

Sangamo Therapeutics, Inc. is a focused PatentsView assignee: 14 CPC subclasses with 97.9% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2018 (26 grants) versus a trough of 7 in 2024. By volume, Sangamo sits between Safran Transmission Systems and Clark Equipment Company.

Sangamo's three-year grant acceleration

From 2019–2021 to 2022–2024, Sangamo Therapeutics, Inc. moved from 67 to 39 grants (0.58x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,492. See the growth leaderboard.

Safran Transmissi…

146
Shenzhen Royole

146
Spin Memory

146
Samsonite IP Hold…

146
Scienbizip Consul…

146
Sangamo Therapeut… ◀

146
Abbott Point of C…

145
Analogic

145
Clark Equipment

145

What this shows Sangamo holds 146 patents at rank #2,670, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sangamo

By rank, the assignees closest to #2,670 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Sangamo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Sangamo, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Sangamo ranks #58 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Innovex Downhole Solutions, Inc. 42 Clover Network, LLC. 42 First Principles, Inc. 42 Simple Living Solutions, LLC 42

Similar claim depth

Nearest assignees by average claims per patent (12.3 here).

Sagemcom Energy & Telecom SAS 12.3 avg University of Georgia Research Foundation, Inc. 12.3 avg Hefei Hualing Co., Ltd. 12.3 avg Bunn-O-Matic Corporation 12.3 avg

Sangamo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Sangamo Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	13	8.9%
2018	26	17.8%
2019	23	15.8%
2020	24	16.4%
2021	20	13.7%
2022	14	9.6%
2023	18	12.3%
2024	7	4.8%
2025partial year	1	0.7%

Which technologies does Sangamo Therapeutics, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 143

C07K - Peptides 108

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 86

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 85

C12Y - Enzymes 43

Y02A - Technologies FOR Adaptation TO Climate Change 14

A01H - NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques 7

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

B01D - Separation 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Sangamo Therapeutics, Inc.'s patent record in context - here's where to go next.

Sangamo Therapeutics, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 97.9% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #2,668 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Sangamo Therapeutics, Inc. against Safran Transmission Systems, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.